Stephens analyst Justin Long raised his price target for Genesee & Wyoming to $83 from $75 following recent developments including an equity offering, the closure of two acquisitions, the announcement of the acquisition of Pentalver and commentary suggesting the short-line tax credit is unlikely to be extended in the near-term. The analyst reiterates an Overweight rating on the shares, saying business fundamentals are on the cusp of inflecting higher and the pipeline for new investments remains active with additional capital deployment being a likely near-term event.